"We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." GoodRx replaces a now-defunct partnership between Novo Nordisk and Hims & Hers, which broke down due to what the drugmaker said were concerns about "illegal mass compounding and deceptive marketing." In a statement, GoodRx chief executive Wendy Barnes said that demand for GLP-1 drugs "is at an all-time high, but too many Americans still face barriers accessing them
The majority of Dihexa research originates from a single laboratory at Washington State University (Wright, Harding, and collaborators)
Its full scientific designation is Body Protection Compound-157, and it has been the subject of over 100 peer-reviewed studies, primarily in animal models, with growing human clinical application
Can persist longer than nausea or diarrhea
This article covers exactly how glutathione interacts with alcohol metabolism, what dosing protocol actually works, and what preparation mistakes negate the benefit entirely
Pancreatitis and biliary disease have also been reported